Ojinmed IVF Center named Specialty Hospital of the Year - Mongolia at Healthcare Asia Awards 2025

Pioneering advancements in fertility care, Ojinmed has helped bring over 1,800 babies into the world through in vitro fertilisation (IVF) in Mongolia.

Ojinmed IVF Center has once again set a new benchmark in fertility treatment, earning the prestigious Specialty Hospital of the Year - Mongolia award at the Healthcare Asia Awards 2025. This recognition highlights Ojinmed’s unwavering commitment to excellence, innovation, and compassionate care, solidifying its position as Mongolia’s premier fertility centre.

Mongolia, a country with a population of approximately 3.4 million, has faced challenges in reproductive health due to geographic dispersion and limited access to advanced fertility treatments. As a nation where family is deeply valued, the demand for world-class fertility services has been growing. Since its founding in 2015, Ojinmed has been at the forefront of providing cutting-edge, science-backed reproductive technologies, allowing countless families to experience the joy of parenthood.

A trailblazer in fertility treatment
Ojinmed is Mongolia’s first and only IVF centre to offer a comprehensive range of advanced reproductive technologies, ensuring patients receive the highest quality care. Amongst its pioneering services are: minimal stimulation & natural cycle IVF, a patient-friendly, low-medication approach to IVF that optimises success whilst reducing risks; preimplantation genetic testing (PGT) for aneuploidy, a revolutionary method for selecting the healthiest embryos, thereby increasing pregnancy success rates; endometrial receptivity analysis (ERA), a cutting-edge test to determine the ideal implantation window for enhanced success; microTESE operation, a life-changing procedure for men with severe infertility, offering new hope for fatherhood; and clean room laboratory system for advanced embryo handling, a precision-driven technology that enhances embryo development and survival rates.

By integrating the latest Japanese technology and state-of-the-art global innovations, Ojinmed has transformed the fertility landscape in Mongolia, giving couples access to internationally recognised reproductive treatments without the need to travel abroad.

Remarkable success rates & unmatched patient care

Ojinmed’s commitment to excellence has led to a dramatic improvement in Mongolia’s fertility success rates. Thanks to its advanced treatment protocols and precision embryo selection through PGT, this clinical pregnancy rate has soared to 85.7% for younger age groups.

Likewise, live birth rates have significantly improved, reaching 52.3% from all implantations, a testament to Ojinmed’s expertise in ovarian response monitoring, advanced embryo freezing techniques, and highly personalised treatment protocols tailored to each patient’s unique needs.

Expanding access to fertility care across Mongolia

Beyond its cutting-edge medical advancements, Ojinmed is deeply committed to making fertility care accessible nationwide. Between 2021 and 2023, its medical team embarked on a groundbreaking outreach initiative, travelling over 14,000 kilometers across 21 provinces to provide infertility diagnostics, testing, and education. This mission has brought critical fertility awareness to thousands, ensuring that hopeful parents, no matter where they live, have access to the information and care they need.

Today, more than 1,850 babies have been conceived through Ojinmed’s IVF programmes, marking a monumental achievement in Mongolia’s reproductive health sector.

A legacy of excellence and innovation

The Healthcare Asia Awards honours medical institutions that redefine excellence through groundbreaking innovation and outstanding contributions to their communities. Ojinmed IVF Center stands proudly amongst Asia’s elite fertility centres, leading the way with its unmatched expertise, cutting-edge technology, and patient-centred approach.

As Mongolia’s premier fertility clinic, Ojinmed continues to push the boundaries of reproductive medicine, turning dreams into reality for families across the country. With its unwavering commitment to excellence, it remains a beacon of hope, innovation, and life itself.

Looking ahead, Ojinmed is planning to expand its services by establishing a National Reproductive Center equipped with AI-driven technology. This next-generation fertility hub aims to revolutionise reproductive healthcare in Mongolia by leveraging artificial intelligence for embryo selection, fertility predictions, and personalised treatment plans, further enhancing success rates and accessibility for aspiring parents.

The Healthcare Asia Awards is presented by Healthcare Asia Magazine. To view the full list of winners, click here. If you want to join the 2026 awards programme and be acclaimed for your organisation's remarkable initiatives and contributions to the healthcare industry, please contact Julie Anne Nuñez at [email protected].